LEVEL 4 R06AE05

Δραστικές

MECLOZINE

Φάρμακα

  • DRUGBANK - Meclizine
  • indication:

    For the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness.

  • pharmacology:

  • mechanism:

    Along with its actions as an antagonist at H<sub>1</sub>-receptors, meclizine also possesses anticholinergic, central nervous system depressant, and local anesthetic effects. Meclizine depresses labyrinth excitability and vestibular stimulation and may affect the medullary chemoreceptor trigger zone.

  • toxicity:

    Symptoms of overdose include drowsiness and anticholinergic effects. LD<sub>50</sub>=mg/kg (orally in rat).

  • absorprion:

    Well absorbed

  • halflife:

    6 hours

  • roouteelimination:

  • volumedistribution:

  • clearance: